Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B-cell tolerance.

Helen Ferry1, Janson C H Leung, Graham Lewis

  • 1Henry Wellcome Building of Molecular Physiology, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.

Transplantation
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response.

Vaccines·2026
Same author

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Aging cell·2026
Same author

Engineering tough blood clots for rapid haemostasis and enhanced regeneration.

Nature·2026
Same author

Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohort.

EBioMedicine·2025
Same author

Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.

Scientific reports·2025
Same author

Time to tackle vaccine-HLA associations with artificial intelligence.

The Lancet. Infectious diseases·2025

B cells encountering abundant self-antigens undergo tolerance. Those recognizing rare self-antigens are controlled by immune checkpoints, offering insights into transplant tolerance and alloantibody generation.

Area of Science:

  • Immunology
  • Autoimmunity
  • Transplantation immunology

Background:

  • Autoreactive B cells are typically eliminated or inactivated through checkpoints like receptor editing and deletion.
  • B cells targeting rare or sequestered self-antigens can remain in a functionally naive state.
  • Immune responses to self-antigens involve complex regulatory mechanisms to prevent autoimmunity.

Purpose of the Study:

  • To review the checkpoints that control autoreactive B cells.
  • To explore how these checkpoints influence the generation of alloantibodies and transplant tolerance.

Main Methods:

  • This study is an overview, synthesizing existing knowledge on B cell tolerance and immune regulation.
  • It analyzes mechanisms controlling self-antigen presentation, costimulatory signals, and germinal center reactions.

Related Experiment Videos

Main Results:

  • Active tolerance mechanisms effectively manage B cells reactive to abundant self-antigens.
  • B cells against rare self-antigens are controlled via antigen presentation, costimulation, and germinal center regulation.
  • Understanding these checkpoints is crucial for deciphering transplant tolerance and alloantibody formation.

Conclusions:

  • Knowledge of B cell tolerance checkpoints provides a framework for understanding transplant tolerance.
  • These insights can inform strategies to prevent or manage alloantibody generation in transplantation.